Cargando…
Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves’ disease
BACKGROUND: Thyrotoxicosis is a cause of secondary osteoporosis. High concentrations of triiodotironine (T3) in Graves’ disease stimulate bone turnover, but it is unclear if euthyroidism will always normalize bone metabolism. Thyrotropin (TSH) is known to affect directly the bone metabolism through...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847206/ https://www.ncbi.nlm.nih.gov/pubmed/24020400 http://dx.doi.org/10.1186/1756-6614-6-11 |
_version_ | 1782293564024160256 |
---|---|
author | Ercolano, Monica A Drnovsek, Monica L Silva Croome, Maria C Moos, Monica Fuentes, Ana M Viale, Fanny Feldt-Rasmussen, Ulla Gauna, Alicia T |
author_facet | Ercolano, Monica A Drnovsek, Monica L Silva Croome, Maria C Moos, Monica Fuentes, Ana M Viale, Fanny Feldt-Rasmussen, Ulla Gauna, Alicia T |
author_sort | Ercolano, Monica A |
collection | PubMed |
description | BACKGROUND: Thyrotoxicosis is a cause of secondary osteoporosis. High concentrations of triiodotironine (T3) in Graves’ disease stimulate bone turnover, but it is unclear if euthyroidism will always normalize bone metabolism. Thyrotropin (TSH) is known to affect directly the bone metabolism through the TSH receptor and TSH receptor antibodies (TRAb) may have an important role in bone turn-over. The aim of our study was to determine, in pre and postmenopausal euthyroidism patients with previous overt hyperthyroidism due to Graves’ disease the bone mineral density (BMD) as well as factors that could affect BMD in each group, including TRAb. METHODS: Cross-sectional, non-interventional study. Fifty-seven patients with previous hyperthyroidism due to Graves’ disease (premenopausal: 30, postmenopausal: 27) that remained euthyroid for at least 6 months prior to study were included and compared with fifty- two matched respective controls. Thyrotoxine (T4), TSH, TRAb and BMD were measured. RESULTS: Only euthyroid postmenopausal patients with a history of hyperthyroidism due to Graves’ disease showed lower whole body BMD than matched controls. The BMD expressed as Z-score was less in whole body and lumbar spine in postmenopausal in relation to premenopausal women with previous overt hyperthyroidism due to Graves’ disease. In the postmenopausal patients, the Z-score of lumbar spine BMD correlated negatively with TRAb (r = −0,53, p < 0.008), positively with the time of evolution of the disease (r = +0.42, p < 0.032) and positively with the time of euthyroidism (r = + 0.50, p < 0.008), but neither with serum T4 nor TSH. In a multiple regression analysis TRAb was the only significant independent variable in relation to lumbar spine BMD (F = 3. 90, p < 0.01). CONCLUSIONS: In euthyroid women with a history of Graves’ hyperthyroidism, BMD was only affected in the postmenopausal group. The negative correlation of Z-score of lumbar spine BMD with TRAb suggests that this antibody may affect the bone metabolism. |
format | Online Article Text |
id | pubmed-3847206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-38472062013-12-04 Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves’ disease Ercolano, Monica A Drnovsek, Monica L Silva Croome, Maria C Moos, Monica Fuentes, Ana M Viale, Fanny Feldt-Rasmussen, Ulla Gauna, Alicia T Thyroid Res Research BACKGROUND: Thyrotoxicosis is a cause of secondary osteoporosis. High concentrations of triiodotironine (T3) in Graves’ disease stimulate bone turnover, but it is unclear if euthyroidism will always normalize bone metabolism. Thyrotropin (TSH) is known to affect directly the bone metabolism through the TSH receptor and TSH receptor antibodies (TRAb) may have an important role in bone turn-over. The aim of our study was to determine, in pre and postmenopausal euthyroidism patients with previous overt hyperthyroidism due to Graves’ disease the bone mineral density (BMD) as well as factors that could affect BMD in each group, including TRAb. METHODS: Cross-sectional, non-interventional study. Fifty-seven patients with previous hyperthyroidism due to Graves’ disease (premenopausal: 30, postmenopausal: 27) that remained euthyroid for at least 6 months prior to study were included and compared with fifty- two matched respective controls. Thyrotoxine (T4), TSH, TRAb and BMD were measured. RESULTS: Only euthyroid postmenopausal patients with a history of hyperthyroidism due to Graves’ disease showed lower whole body BMD than matched controls. The BMD expressed as Z-score was less in whole body and lumbar spine in postmenopausal in relation to premenopausal women with previous overt hyperthyroidism due to Graves’ disease. In the postmenopausal patients, the Z-score of lumbar spine BMD correlated negatively with TRAb (r = −0,53, p < 0.008), positively with the time of evolution of the disease (r = +0.42, p < 0.032) and positively with the time of euthyroidism (r = + 0.50, p < 0.008), but neither with serum T4 nor TSH. In a multiple regression analysis TRAb was the only significant independent variable in relation to lumbar spine BMD (F = 3. 90, p < 0.01). CONCLUSIONS: In euthyroid women with a history of Graves’ hyperthyroidism, BMD was only affected in the postmenopausal group. The negative correlation of Z-score of lumbar spine BMD with TRAb suggests that this antibody may affect the bone metabolism. BioMed Central 2013-09-11 /pmc/articles/PMC3847206/ /pubmed/24020400 http://dx.doi.org/10.1186/1756-6614-6-11 Text en Copyright © 2013 Ercolano et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Ercolano, Monica A Drnovsek, Monica L Silva Croome, Maria C Moos, Monica Fuentes, Ana M Viale, Fanny Feldt-Rasmussen, Ulla Gauna, Alicia T Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves’ disease |
title | Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves’ disease |
title_full | Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves’ disease |
title_fullStr | Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves’ disease |
title_full_unstemmed | Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves’ disease |
title_short | Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves’ disease |
title_sort | negative correlation between bone mineral density and tsh receptor antibodies in long-term euthyroid postmenopausal women with treated graves’ disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847206/ https://www.ncbi.nlm.nih.gov/pubmed/24020400 http://dx.doi.org/10.1186/1756-6614-6-11 |
work_keys_str_mv | AT ercolanomonicaa negativecorrelationbetweenbonemineraldensityandtshreceptorantibodiesinlongtermeuthyroidpostmenopausalwomenwithtreatedgravesdisease AT drnovsekmonical negativecorrelationbetweenbonemineraldensityandtshreceptorantibodiesinlongtermeuthyroidpostmenopausalwomenwithtreatedgravesdisease AT silvacroomemariac negativecorrelationbetweenbonemineraldensityandtshreceptorantibodiesinlongtermeuthyroidpostmenopausalwomenwithtreatedgravesdisease AT moosmonica negativecorrelationbetweenbonemineraldensityandtshreceptorantibodiesinlongtermeuthyroidpostmenopausalwomenwithtreatedgravesdisease AT fuentesanam negativecorrelationbetweenbonemineraldensityandtshreceptorantibodiesinlongtermeuthyroidpostmenopausalwomenwithtreatedgravesdisease AT vialefanny negativecorrelationbetweenbonemineraldensityandtshreceptorantibodiesinlongtermeuthyroidpostmenopausalwomenwithtreatedgravesdisease AT feldtrasmussenulla negativecorrelationbetweenbonemineraldensityandtshreceptorantibodiesinlongtermeuthyroidpostmenopausalwomenwithtreatedgravesdisease AT gaunaaliciat negativecorrelationbetweenbonemineraldensityandtshreceptorantibodiesinlongtermeuthyroidpostmenopausalwomenwithtreatedgravesdisease |